← Russell 3000 cross-section

OVV Ovintiv Inc.

Trailing twelve months to 2026-06-30 · as filed 2026-07-23, not restated
Energy

Scale

Market cap
$17.7bn
Revenue TTM
$9.5bn
Net income TTM
$920m
Free cash flow
$2.3bn
Composite score
53.6
Sector rank
#488

Valuation

P / E
19.2
EV / EBITDA
6.7
EV / sales
2.2
FCF yield
12.82%
Earnings yield vs 10-yr
0.47pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
9.7%
EBITDA margin
32.6%
ROE
8.0%
ROIC
6.5%
Revenue growth
6.4%

Insider activity, last 90 days

Net open-market
$-0.49m
Buyers
0
Sellers
1

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

Additionally, pro forma net earnings were adjusted to exclude transaction-related costs incurred of approximately $ 27 million recognized by Ovintiv and $ 22 million recognized by NuVista during the six months ended June 30, 2026. The non-cash ceiling test impairments primarily resulted from declines in the 12-month average trailing prices which reduced proved reserves in the USA Operations, and the 12-month average trailing prices used in the ceiling test at March 31, 2026, which were lower than the market prices used for the NuVista Acquisition on February 3, 2026, in the Canadian Operations. …Ovintiv Inc., 10-Q, period ended 2026-06-30, filed 2026-07-23

Read the full passage →